Somalogic
SomaLogic Revenues Almost Triple in First Half of 2021
For the six months ended June 30, the Boulder, Colorado-based company posted revenues of $38.6 million, up from $13.4 million in the year-ago period.
SomaLogic to List on Nasdaq Following SPAC Merger, Raises $630M
Through the transaction, which values SomaLogic at roughly $1.2 billion, the company received gross cash proceeds of approximately $630 million.
SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent
The company said that it expects to exceed its previous full-year 2021 guidance of $66.7 million in revenues by 10 percent or more.
Experts cautioned, however, that firms will need a broader portfolio than just COVID-19 testing for sustainability in the public markets.
The proteomics firm is working with four health providers to assess how its tests can improve delivery of care and to map out potential new use cases.
Nov 25, 2020
Somalogic Closes $121M Series A Funding
Sep 17, 2019
Jan 18, 2019
Nov 27, 2017
May 25, 2017
Dec 6, 2016
Jun 22, 2016